Sleep Disorders: Clinical Trials

12 trials for Sleep Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 12

Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impacts of Low-Dose Dexmedetomidine on Sleep Quality in Mechanically Ventilated ICU Patients
Dexmedetomidine, Placebo (normal saline) - Aged, Postoperative Period
Phase 4CompletedPeking University First Hospital802017-11-172019-12-11
Effect of Melatonin on Sleep Quality in Patients Dementia
Melatonin 5 mg, Placebo - Sleep Disorders, Dementia
Phase 4CompletedHospital Universitario Dr. Jose E. Gonzalez402016-01-152017-02-28
Atripla to Stribild Switch Study to Evaluate Sleep Disturbances
Stribild - HIV, AIDS
Phase 4CompletedMidtown Medical Center, Tampa, FL212015-02-012017-07-28
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Milnacipran, Placebo - Sleep Disorders, Fibromyalgia
Phase 4CompletedMansoor Ahmed M.D.192010-11-012019-08-21
Sleep Satisfaction and Psychomotor Performance of Adults
ZOLPIDEM - Sleep Disorders
Phase 4CompletedSanofi302010-03-012012-07-17
Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA
ZOLPIDEM SL800750 - Sleep Disorders
Phase 4CompletedSanofi1352009-11-012010-10-05
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
armodafinil, placebo - Sleep Disorders, Obstructive Sleep Apnea
Phase 4CompletedCephalon2492007-10-012013-07-19
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
Ramelteon, Placebo - Insomnia, Spinal Cord Injury
Phase 4CompletedUS Department of Veterans Affairs122007-07-012014-05-22
Impact of Smoking Cessation on Sleep - 5
Bupropion, Transdermal Nicotine Patch, Placebo Bupropion - Tobacco Use Cessation, Sleep Disorders
Phase 4CompletedNational Institute on Drug Abuse (NIDA)592005-08-012017-01-12
Study Evaluating TotelleĀ® in Menopausal Symptoms and Sexual Function
TotelleĀ® - Hot Flashes, Sleep Disorders
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer1002004-12-012008-08-05
Insomnia and Daytime Function in Osteoarthritis
zolpidem - Sleep Disorders
Phase 4CompletedSanofi1702003-03-012012-02-17
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
Zolpidem, Escitalopram, Placebo - Sleep Disorders
Phase 4CompletedUniversity of Pittsburgh692002-02-012016-03-30

Narrower conditions

Sleep Wake Disorders (12)  ·  Sleep Initiation and Maintenance Disorders (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Dementia (1)  ·  Depressive Disorder, Major (1)  ·  Disorders of Excessive Somnolence (1)  ·  Dysthymic Disorder (1)  ·  Fibromyalgia (1)  ·  Hot Flashes (1)  ·  Quadriplegia (1)  ·  Recurrence (1)  ·  Sleep Apnea, Obstructive (1)  ·  Smoking Cessation (1)  ·  Spinal Cord Injuries (1)  ·  Tobacco Use Cessation (1)

Broader conditions

Mental Disorders (12)  ·  Nervous System Diseases (12)  ·  Neurologic Manifestations (12)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Signs and Symptoms (12)  ·  Dyssomnias (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Central Nervous System Diseases (2)  ·  Apnea (1)  ·  Behavior (1)  ·  Blood-Borne Infections (1)  ·  Brain Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Communicable Diseases (1)  ·  Depressive Disorder (1)

Interventions

Zolpidem (4)  ·  Bupropion (1)  ·  Citalopram (1)  ·  Dexmedetomidine (1)  ·  Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Escitalopram (1)  ·  Melatonin (1)  ·  Milnacipran (1)  ·  Modafinil (1)  ·  Saline Solution (1)  ·  Sugars (1)  ·  Tobacco Use Cessation Devices (1)  ·  pyrithyldione (1)  ·  ramelteon (1)

Sponsors

Sanofi (3)  ·  Cephalon (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Mansoor Ahmed M.D. (1)  ·  Midtown Medical Center, Tampa, FL (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  Peking University First Hospital (1)  ·  US Department of Veterans Affairs (1)  ·  University of Pittsburgh (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

United States (5)  ·  Argentina (1)  ·  Brazil (1)  ·  China (1)  ·  Mexico (1)

Top investigators

Daniel J. Buysse, MD (1)  ·  Dong-Xin Wang, MD, PhD (1)  ·  Edward W Braun, MD (1)  ·  Gary Swan (1)  ·  Guillermo Guajardo, MD (1)  ·  Jamie M. Zeitzer, PhD (1)  ·  Mansoor Ahmed, MD (1)  ·  Noel Cyrill, MD (1)  ·  Nosson S Goldfarb, M.D. (1)  ·  Rozina Aamir, MS, MBA (1)

Results publications

PMID 20051221, PMID 24090266, PMID 26414990, PMID 33189083, PMID 34674490, PMID 36117973

NIH funding

R01MH024652 (1)